> top > docs > PMC:7264098 > spans > 171-1880 > annotations

PMC:7264098 / 171-1880 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T7 77-85 SP_7 denotes COVID-19
T8 109-114 NCBITaxon:10239 denotes viral
T9 135-159 CHEBI:67079;CHEBI:67079 denotes anti-inflammatory agents
T10 304-308 UBERON:0002048 denotes lung
T11 343-352 CL:0000034 denotes Stem cell
T12 389-397 GO:0046903 denotes secreted
T13 398-420 GO:1903561 denotes extracellular vesicles
T14 529-533 UBERON:0002048 denotes lung
T15 551-559 SP_7 denotes COVID-19
T16 561-571 CL:0000034 denotes Stem cells
T17 602-607 CHEBI:67079;CHEBI:67079 denotes anti-
T18 607-614 CHEBI:63248;CHEBI:63248 denotes oxidant
T19 748-766 CHEBI:52217;CHEBI:52217 denotes therapeutic agents
T20 771-777 NCBITaxon:9606 denotes people
T21 783-791 SP_7 denotes COVID-19
T22 865-869 UBERON:0002048 denotes lung
T23 887-897 SP_7 denotes SARS-CoV-2
T24 898-903 NCBITaxon:10239 denotes virus
T25 915-923 SP_7 denotes COVID-19
T26 940-951 UBERON:0003104;CL:0000134 denotes mesenchymal
T27 952-962 CL:0000034 denotes stem cells
T28 964-968 DG_47 denotes MSCs
T29 980-988 GO:0046903 denotes secreted
T30 1160-1175 CHEBI:52217;CHEBI:52217 denotes pharmacological
T31 1267-1271 DG_47 denotes MSCs
T32 1293-1301 SP_7 denotes COVID-19
T33 1405-1413 GO:0070062 denotes exosomes
T34 1700-1708 SP_7 denotes COVID-19
T51882 77-85 SP_7 denotes COVID-19
T46577 109-114 NCBITaxon:10239 denotes viral
T12680 135-159 CHEBI:67079;CHEBI:67079 denotes anti-inflammatory agents
T17011 304-308 UBERON:0002048 denotes lung
T58760 343-352 CL:0000034 denotes Stem cell
T64561 389-397 GO:0046903 denotes secreted
T18890 398-420 GO:1903561 denotes extracellular vesicles
T99029 529-533 UBERON:0002048 denotes lung
T42833 551-559 SP_7 denotes COVID-19
T30050 561-571 CL:0000034 denotes Stem cells
T21623 602-607 CHEBI:67079;CHEBI:67079 denotes anti-
T52171 607-614 CHEBI:63248;CHEBI:63248 denotes oxidant
T81443 748-766 CHEBI:52217;CHEBI:52217 denotes therapeutic agents
T27870 771-777 NCBITaxon:9606 denotes people
T85363 783-791 SP_7 denotes COVID-19
T95711 865-869 UBERON:0002048 denotes lung
T84477 887-897 SP_7 denotes SARS-CoV-2
T85152 898-903 NCBITaxon:10239 denotes virus
T26206 915-923 SP_7 denotes COVID-19
T50420 940-951 UBERON:0003104;CL:0000134 denotes mesenchymal
T65832 952-962 CL:0000034 denotes stem cells
T45368 964-968 DG_47 denotes MSCs
T88437 980-988 GO:0046903 denotes secreted
T5958 1160-1175 CHEBI:52217;CHEBI:52217 denotes pharmacological
T35718 1267-1271 DG_47 denotes MSCs
T92850 1293-1301 SP_7 denotes COVID-19
T19373 1405-1413 GO:0070062 denotes exosomes
T87580 1700-1708 SP_7 denotes COVID-19

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
19 196-203 Species denotes patient Tax:9606
20 771-777 Species denotes people Tax:9606
21 887-897 Species denotes SARS-CoV-2 Tax:2697049
22 77-85 Disease denotes COVID-19 MESH:C000657245
23 304-315 Disease denotes lung damage MESH:D008171
24 492-504 Disease denotes inflammation MESH:D007249
25 529-540 Disease denotes lung damage MESH:D008171
26 551-559 Disease denotes COVID-19 MESH:C000657245
27 783-791 Disease denotes COVID-19 MESH:C000657245
28 865-876 Disease denotes lung damage MESH:D008171
29 915-923 Disease denotes COVID-19 MESH:C000657245
30 1293-1301 Disease denotes COVID-19 MESH:C000657245
31 1700-1708 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T6 304-308 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T7 343-352 Body_part denotes Stem cell http://purl.org/sig/ont/fma/fma63368
T8 348-352 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T9 529-533 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T10 561-571 Body_part denotes Stem cells http://purl.org/sig/ont/fma/fma63368
T11 566-571 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T12 846-854 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T13 865-869 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T14 940-962 Body_part denotes mesenchymal stem cells http://purl.org/sig/ont/fma/fma0326143
T15 957-962 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T2 304-308 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T3 529-533 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T4 865-869 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 77-85 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 492-504 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T6 551-559 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 783-791 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T8 887-895 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T9 887-891 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T10 915-923 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T11 1293-1301 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1700-1708 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T5 0-1 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T6 304-308 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T7 304-308 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T8 343-352 http://purl.obolibrary.org/obo/CL_0000034 denotes Stem cell
T9 529-533 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T10 529-533 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T11 561-571 http://purl.obolibrary.org/obo/CL_0000034 denotes Stem cells
T12 865-869 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T13 865-869 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T14 898-903 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T15 940-962 http://purl.obolibrary.org/obo/CL_0000134 denotes mesenchymal stem cells
T16 1385-1392 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 135-159 Chemical denotes anti-inflammatory agents http://purl.obolibrary.org/obo/CHEBI_67079
T2 607-614 Chemical denotes oxidant http://purl.obolibrary.org/obo/CHEBI_63248

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 492-504 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 0-160 Sentence denotes A number of medicines are currently under investigation for the treatment of COVID-19 disease including anti-viral, anti-malarial, and anti-inflammatory agents.
T5 161-342 Sentence denotes While these treatments can improve patient's recovery and survival, these therapeutic strategies do not lead to unequivocal restoration of the lung damage inflicted by this disease.
T6 343-560 Sentence denotes Stem cell therapies and, more recently, their secreted extracellular vesicles (EVs), are emerging as new promising treatments, which could attenuate inflammation but also regenerate the lung damage caused by COVID-19.
T7 561-792 Sentence denotes Stem cells exert their immunomodulatory, anti-oxidant, and reparative therapeutic effects likely through their EVs, and therefore, could be beneficial, alone or in combination with other therapeutic agents, in people with COVID-19.
T8 793-1187 Sentence denotes In this review article, we outline the mechanisms of cytokine storm and lung damage caused by SARS-CoV-2 virus leading to COVID-19 disease and how mesenchymal stem cells (MSCs) and their secreted EVs can be utilized to tackle this damage by harnessing their regenerative properties, which gives them potential enhanced clinical utility compared to other investigated pharmacological treatments.
T9 1188-1435 Sentence denotes There are currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with only one clinical trial testing MSC-derived exosomes via inhalation route.
T10 1436-1709 Sentence denotes While we wait for the outcomes from these trials to be reported, here we emphasize opportunities and risks associated with these therapies, as well as delineate the major roadblocks to progressing these promising curative therapies toward mainstream treatment for COVID-19.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 846-860 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041